One more note: because DSIP is still under investigation (and regulatory status varies), both delivery routes are best viewed as experimental or investigational not as guaranteed therapies
The group argued that where there is a legitimate patient need, allowing peptides to be compounded by state-licensed pharmacies would provide greater oversight through prescription requirements, quality standards, inspections and adverse-event reporting
If you are a competitive athlete, verify BPC-157s status with major anti-doping agencies
AOD-9604 (metabolic support) Article: What you need to know about AOD-9604 AOD-9604 has been studied as a fat-burning and metabolic health peptide that has potential to help with body composition and anti-aging.
Final Thoughts You can expect to see results within 2-4 weeks, depending on the severity of your condition
Subcutaneous dosing in research protocols is typically in the 1-2 mg range, though specific doses depend entirely on the study design and model